(Q37732534)

22 August 2017

1 reference

title

Determinants of response and prediction of response to chemotherapy in acute myelogenous leukemia (English)

1 reference

22 August 2017

1 reference

1 reference

Preisler HD

1

1 reference

22 August 2017

publication date

1 January 1991

1 reference

Best Practice and Research: Clinical Haematology

22 August 2017

published in

1 reference

22 August 2017

volume

4

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

69-96

1 reference

Differentiation of myeloid cells in liquid culture: 2. Acute myelocytic leukemia cells

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

The biochemistry of P-glycoprotein-mediated multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

A new approach to the detection of DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Effects of a hemoregulatory peptide (HP5b) on erythroid and myelopoietic colony formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

1 reference

7 January 2021

Patterns of maturation in short-term culture of human acute myeloid leukaemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Failure of remission induction in acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

The treatment of acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: Relationship to response to remission induction therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Relationship between leukemic cell retention of cytosine arabinoside triphosphate and the duration of remission in patients with acute non-lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Assessment of c-myc expression in individual leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Ph1-positive acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Heterogeneity of clonogenic cells in acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Expression of the multidrug resistance gene in myeloid leukemias.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Studies of the proliferation and differentiation of immature myeloid cells in vitro. II. Acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980285-9

7 January 2021

10.1016/S0950-3536(05)80285-9

Identifiers

DOI

1 reference

22 August 2017

1 reference